Importantly, we detected a considerable increase in COX2 and Treg, two well-known players in the modulation of type 1 immunity, HEV integrity, and CD8 T cell accumulation, which are likely impacting tumor-associated TLO in prostate cancer. This evidence concerns the gene CD8A and prostate cancer.